Results of Haleon 2026 Annual General Meeting

HALEON

29/04/2026 16:48

RNS Number : 4592C

Haleon PLC

29 April 2026

 

Haleon plc: Results of Haleon 2026 Annual General Meeting

 

29 April 2026: Haleon plc (the "Company" or "Haleon) (LSE/NYSE: HLN) announces that the following resolutions were decided by poll vote at the Company's 2026 Annual General Meeting ("AGM") which was held today.

 

Resolutions 20, 21, 22 and 23 were passed as special resolutions; all other resolutions were passed as ordinary resolutions. Full text of the resolutions is contained in the Company's Notice of 2026 AGM, which is available at www.haleon.com.

 

Haleon plc - Poll Results

 

Resolution
Votes for
For (% of shares voted)
Votes against
Against (% of shares voted)
Total votes cast (excluding withheld)
% of issued share capital voted1
Votes withheld2
1
To receive the Annual Report & Accounts
7,518,381,689
99.99
974,818
0.01
7,519,356,507
84.57%
41,371,913
2
To approve the Directors' Remuneration Report
7,385,589,576
98.00
151,074,594
2.00
7,536,664,170
84.77%
24,063,940
3
To approve the Directors' Remuneration Policy
7,133,534,799
94.65
402,883,378
5.35
7,536,418,177
84.76%
24,310,243
4
To declare a final dividend
7,540,340,495
99.99
1,088,307
0.01
7,541,428,802
84.82%
19,299,618
5
To re-elect Manvinder Singh (Vindi) Banga
7,508,532,595
99.57
32,203,620
0.43
7,540,736,215
84.81%
19,991,895
6
To re-elect Brian McNamara
7,506,462,082
99.54
34,382,494
0.46
7,540,844,576
84.81%
19,883,534
7
To re-elect Dawn Allen
7,464,666,016
98.99
76,193,454
1.01
7,540,859,470
84.81%
19,868,950
8
To re-elect Alan Stewart
7,523,725,090
99.77
17,312,615
0.23
7,541,037,705
84.82%
19,690,715
9
To re-elect Nancy Avila
7,527,476,825
99.83
13,173,973
0.17
7,540,650,798
84.81%
20,077,622
10
To re-elect Marie-Anne Aymerich
7,514,059,525
99.84
11,924,672
0.16
7,525,984,197
84.65%
34,743,913
11
To re-elect Bláthnaid Bergin
7,535,655,488
99.93
5,031,351
0.07
7,540,686,839
84.81%
20,041,582
12
To re-elect Tracy Clarke
7,496,699,209
99.41
44,348,201
0.59
7,541,047,410
84.82%
19,677,335
13
To re-elect Dame Vivienne Cox
7,517,554,491
99.69
23,507,481
0.31
7,541,061,972
84.82%
19,666,449
14
To re-elect Asmita Dubey
7,536,859,688
99.95
3,756,869
0.05
7,540,616,557
84.81%
20,111,863
15
To elect Matthew Shattock
7,537,243,742
99.96
3,237,791
0.04
7,540,481,533
84.81%
20,246,887
16
To re-appoint KPMG as auditor of the Company
7,539,941,050
99.98
1,220,592
0.02
7,541,161,642
84.82%
19,561,576
17
To authorise the Audit & Risk Committee to set the auditor's remuneration
7,539,239,644
99.98
1,669,241
0.02
7,540,908,885
84.81%
19,819,535
18
To authorise the Company to make political donations
7,438,001,218
99.00
75,178,085
1.00
7,513,179,303
84.50%
47,549,118
19
To authorise the Directors to allot ordinary shares
7,248,168,508
96.12
292,273,298
3.88
7,540,441,806
84.81%
20,286,615
20
General authority to disapply pre-emption rights
7,177,724,786
95.20
361,654,667
4.80
7,539,379,453
84.80%
21,348,967
21
Additional authority to disapply pre-emption rights
6,995,143,055
92.78
544,236,758
7.22
7,539,379,813
84.80%
21,348,334
22
To authorise a 14-day notice period for general meetings
7,054,966,644
93.56
485,779,174
6.44
7,540,745,818
84.81%
19,982,603
23
To authorise the Company to purchase its own shares
7,533,340,747
99.93
5,392,478
0.07
7,538,733,225
84.79%
21,991,442

 

1 For the purposes of section 341 of the Companies Act 2006, as at 6:30pm (BST) on Friday, 24 April 2026, Haleon's issued share capital was 8,903,405,354 ordinary shares of £0.01 each, 12,281,053 of which were held as treasury shares. Therefore, the total voting rights in the Company were 8,891,124,301.

2 A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

 

As required by the UK Listing Rule 6.4.2R of the Financial Conduct Authority ("FCA"), copies of resolutions passed by the Company other than resolutions concerning ordinary business have been submitted to the FCA via the National Storage Mechanism and will shortly be available to the public for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

 

Amanda Mellor 

Company Secretary 

 

About Haleon

Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused on better everyday health. Our people, our brands, our research, our investment and our innovation are aimed at improving the everyday health of consumers. Our product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Our superior brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are trusted by more than one billion consumers and are recommended by health professionals around the world.

 

For more information, please visit www.haleon.com. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
RAGEKLFLQZLZBBZ